International Journal of High Dilution Research - ISSN 1982-6206 2021-04-06T13:08:22+02:00 Prof. Leoni Villano Bonamin Open Journal Systems <div style="width: 100%; text-align: justify; font-size: 12px;">IJHDR is the first full free open-access electronic journal specializing in the multidisciplinary field of High Dilution (HD) research. Hosted by GIRI and supported by HRI (, it is peer-reviewed, with an international editorial board and published quarterly. Indexed at LILACS/BIREME/PAHO/WHO and EBSCO, and inserted at SCOPUS, Qualis-CAPES, Latindex, OJS/PKP, Google Scholar, DOAJ, NSDL/NSF, Open J-Gate, JournalSeek, and BVS.</div> <div style="width: 100%; text-align: justify; font-size: 12px;">IJHDR counts on the service of ABEC and Crossref. Eventual plagiarism is checked by the iThenticate service.</div> Homeopathy in the treatment of COVID-19 2021-03-28T17:22:12+02:00 Carla Holandino Maria Olga Kokornaczyk <p>An Extraordinary GIRI Meeting took place on the 26 and 27 of November 2020. Due to the current situation, it was held on the ZOOM platform. It regarded the clinical and basic research on COVID-19 and the coronavirus exclusively. The meeting was organized in partnership with the Federal University of Rio de Janeiro (UFRJ) and the International Research Group on Very Low Dosis and High Dilution Effects (GIRI) as a pre-event to the V International Homeopathy Workshop of UFRJ, planned for 2-4 December 2021.</p> <p>During a pandemic, when there is a general lack of workers, equipment, and medicines, any kind of treatment capable of maintaining or improving people’s health should be considered by all medical facilities. Therefore, the GIRI meeting aimed to collect, discuss, and disseminate knowledge and medical experience gathered by homeopathy researchers and doctors around the world regarding the possibility of treating COVID-19 with homeopathy. The meeting lasted two days and was visited by a large number of participants from Brazil, India, Russia, Belgium, Hong Kong, Switzerland, and England, gathering so researchers, professionals, and many students from different fields of expertise, e.g. pharmacology, medicine, biology, physics, veterinary, chemistry.&nbsp;</p> <p>In total, 11 abstracts were approved by a Scientific Committee and presented in a 30-60 min oral contribution. The meeting was interactive, offering space for questions, answers, and for many discussions concerning the potential of homeopathy in the context of COVID-19. The conference provided the possibility to better understand the different homeopathic approaches in the treatment of COVID-19, such as the use of nosodes (prepared from virus particles), that showed a promising immunomodulatory and prophylactic potential. Further, the preliminary analysis of the Clificol COVID-19 support project was presented, revealing a vast international panorama concerning the use of homeopathy in different countries. There were other contributions regarding the use of homeopathy in adults and children for the treatment of COVID-19.</p> <p>To disseminate even further the findings presented at the Extraordinary GIRI Meeting 2020 related to the role of homeopathy in the COVID-19 pandemic, we are launching this special issue of the International Journal of High Dilution Research (IJHDR).</p> 2021-04-06T00:00:00+02:00 Copyright (c) 2021 Carla Holandino, Maria Olga Kokornaczyk COVID-19: cases cured with Homoeopathy 2021-03-14T13:19:13+01:00 Abdequaem Chimthanawala <p>Background: Homoeopathy is a medical science that should be practiced with evidence. As a practitioner, I was keen to show how Homoeopathy can give relief in this pandemic where conventional therapy was also struggling to offer treatment. Homoeopathic remedies given in Covid-19 cases in my OPD were prescribed to patients 1. who took only Homoeopathy, 2. who took Allopathy but got no relief and 3. hospitalized yet got relief with Homoeopathy. Few cases which did not get symptomatic relief were advised to stop treatment. Aims: To see the efficacy of Homoeopathy in treating covid 19 patients – with mild, moderate, and severe symptoms. Methodology: Data collected after permission from the patients to share case studies for Homoeopathy treatment of Covid-19 were obtained from GraceHealing Homeopathy clinic in Nagpur were categorized as mild to moderate and moderate to severe as per AYUSH guidelines; similimum with matching potency prescribed after detailed case inquiry, and regular Follow-ups were done until patients felt relief. Hypothesis: To see the action of Homoeopathy similimum - as a palliative, curative, and no action in treating covid-19 cases. Results: Homoeopathy has shown definite results in mild to moderate and moderate to severe cases up to 80% relief in mild to moderate 60% in moderate to severe. Mild to moderate cases where only Homoeopathy was given: China-ars, Ferrum-p, and Gelsemium were satisfactory. Baptisia and Carb-v adjuvant to Allopathy was also satisfactory. In hospitalized severe case gave relief, where Allopathy did not help. If Homoeopathy was given in such cases, it acts in increasing the immunity to make healing faster: Kali carb and Nux vomica satisfactory. Conclusion: With detailed case inquiry, symptomatic treatment with simillimum in correct potency can give Covid 19 patients relief.</p> 2021-04-06T00:00:00+02:00 Copyright (c) 2021 Abdequaem Chimthanawala Therapy of coronavirus infection 2021-03-14T13:33:45+01:00 Tatiana Akaeva Karen Mkhitaryan Olesya Vasilkovskaya <p>Background: The computer apparatus for electro-acupuncture diagnostics and medicated testing "IMEDIS-EXPERT" made in Russia was used for the purposes of this work to detect SARS-CoV-2 (COVID-19) or to prove its absence, and to select homoeopathic preparations, nosodes, and their relevant doses. The methods of the system-nosological approach (SNA) were used for the therapy of patients, which included recording and appliance of relevant control signals (C.S.) of homoeopathic preparations, both native and informational (electronic) copies. Aims: 1. Develop an algorithm to select preparations from the group of nosodes and homoeopathy to prevent the development of SARS-CoV-2 (COVID-19); 2. Evaluate the possibility of preventing treatment and therapy of coronavirus infection employing an "electronic vaccine" produced employing coronavirus C.S. Methodology: The electronic preventing "immunization" was made for patients as the preventing treatment of COVID-19, which was an adaptation to coronavirus C.S. conducted in accordance with a special algorithm. The three-block scheme of SNA therapy was used for the therapy of ill patients, which was composed of three preparations, which were used sequentially: 1. Control signal of coronavirus targeted on a patient's CMH; 2. Cerebral response (C.R.) with a patient's cumulative impact of: C.S. of coronavirus and the sum of target organs (blood-forming system, lymphatic systems, lungs, bronchus, gastrointestinal system) and test-indicators of immune regulation targeted on the second CMH marker amplification; 3. Drainages in the form of homeopathic preparations were used (after the impact of two previous preparations), which were: Arsenicum, Arsenicum iod, Carbo vegetabilis, Spongia, Drosera, Naya, Rhus Toxicodendron, and Ferrum met. The preparations were selected to compensate the third impact of CMH. Results: At present, 175 people have asked for help due to COVID-19, an electronic preventing vaccine ("immunization") made for 112 people on the SNA algorithm. According to the diagnostic testing results made for 63 ill patients and who asked for treatment: 47 people tested coronavirus infection, 16 people tested ARVI, and 12 people tested pneumonia caused by a virus. The coincidence of VRT tests (vegetative resonance tests) and PCR was found ranged from 68 to 75%. 4 people got ill by coronavirus among those who got preventing immunization (112 people) by "the electronic sensibilization method" (that was proved by VRT and PCR tests). The illness had the light form among 2 of them, and two people had moderate severity of illness without hospital admission. Conclusion: An algorithm is developed, which allows to select C.S. of therapeutic nosodes and homoeopathic preparations to prevent the development of SARS-CoV-2. The efficiency of applying the electronic immunization method according to the algorithms of SNA using coronavirus C.S. is 95%.</p> 2021-04-06T00:00:00+02:00 Copyright (c) 2021 Tatiana Akaeva, Karen Mkhitaryan, Olesya Vasilkovskaya Survey COVID-19 first peak 2020 2021-03-14T13:53:52+01:00 Philippe Devos Michael Van Wassenhoven Paul Serneels Pablo Serneels Martine Goyens <p>Background: In Belgium, the first peak of COVID-19 was observed between March and April 2020. This represented more than 300 deaths a day beginning April and more than 1500 new cases every day during this period. Aims: This retrospective observational survey of the practice of Homeopathic Medical Doctors in Belgium has been conducted to check Belgian Homeopathic Doctors (HMD) have treated their patients presenting mild symptoms of COVID-19. Methodology: 6 HMDs accepted to provide data from all consecutive cases treated for COVID-19 symptoms in March and April 2020. This systematic retrospective data collection was compared with information from a free exchange HMDs’ forum. 13 HMDs regularly participated in this forum. Results and discussion: this survey included 313 patients presenting mild COVID-19 symptoms. The efficiency score (healing of symptoms in less than eight days) is relevant for 83,1% of these patients. The average duration of COVID-19 symptoms is 20 days. The four most used homeopathic medicines (Bryonia alba/Arsenicum album/Phosphorus/Gelsemium sempervirens) were prescribed to 66% of them. 1,3% needed hospitalization for some time. Not any loss of chance to cure occurred for patients that used homeopathy for COVID-19 symptoms. Market data also reveals that homeopathy has been largely used to prevent and heal during the early peak of COVID-19 in Belgium. This survey allows us to conclude that during such an epidemic situation for which no effective therapy exists and no vaccination is possible, homeopathy should be considered a valuable approach.</p> 2021-04-06T00:00:00+02:00 Copyright (c) 2021 Philippe Devos, Michael Van Wassenhoven, Paul Serneels, Pablo Serneels, Martine Goyens Preliminary analysis of the Clificol COVID-19 support project 2021-03-14T15:35:40+01:00 Alexander Tournier Yuen Ying Yvonne Fok <p>Background: The Clificol® COVID-19 Support Project is an innovative international project set up during the current crisis to register cases of Covid which received adjunctive homeopathic care. Aims The project aims to describe the demographics, geographic specificities, and time-courses of the cases and shed some light on the notion of Genus Epidemicus in the context of this infection. Beyond this, the project aims to use the data to tackle more fundamental questions in homeopathy, such as the notion of Individualization and the 'Law of Similars’. Methodology: This online multi-national data-collection project receives the support of ECH, ECCH, ICH, HRI, LMHI, and other professional associations; the Governance Committee now consists of 11 representatives, representing 197 associations. The study is designed as an observational study, and standardized consent terms were used to gather anonymized data. The collected data consists of demographic information, severity, conventional diagnosis, treatment, presenting symptoms, and a remedy prescribed at each consultation. The course of the condition is tracked using the ORIDL scale. Besides basic statistics regarding demographics, the notion of Individualisation is investigated by analyzing whether presenting symptoms cluster into tight groups as would be expected by the homeopathic principle of Individualisation (K-Means clustering approach). The connection – Law of Similars – between symptoms and a successful remedy are analyzed using logistic regression modelling (SPSS). Results and discussion: Up-to-date demographic data will be presented at the conference. The preliminary analysis picked up the two most common remedies pictures corresponding to Gelsemium sempervirens (Cluster 1) and Bryonia alba (Cluster 3). Interestingly it found another remedy picture (Cluster 2), which had a much lower success rate (75%) compared to cluster 1 (99%) and 3 (100%). In the preliminary analysis, statistically significant regression models for Gelsemium and Bryonia were built. These show that indeed there is a consistent link – that can be statistically modelled - between sets of symptoms and a successful remedy. With sufficient data, the modelling can be extended to explore the notions of ‘Keynote Symptom’ and ‘Three-Legged Stool’ to see whether such key symptoms or sets of symptoms do indeed come out from the analysis. The approach is limited by the natural inclination of homeopaths to see the symptoms of remedy they think is required in the patient. We hope to be able to use the data to shed some light on this type of bias. Conclusion: The data collected during this pandemic offers a unique opportunity to shed light on some of the core principles of homeopathy. The preliminary analysis is presented to demonstrate the potential of the approach and how powerful it can be provided enough data is gathered. The Clificol COVID-19 data collection project, currently supported by most organizations worldwide, requires more cases to fulfil its ambitious aims.</p> 2021-04-06T00:00:00+02:00 Copyright (c) 2021 Alexander Tournier, Yuen Ying Yvonne Fok Updates from China: clinical and research experience of homeopathy in the pandemic 2021-03-14T15:42:30+01:00 Ka Lun Aaron To Yuen Ying Yvonne Fok <p>Background: Hong Kong is one of the regions which is most affected by the COVID-19 pandemic in China. In homeopathy, common pathognomonic symptoms are less informative, while homeopathic symptoms are always more helpful for homeopathic prescriptions. Aims: The first case series from Hong Kong was presented and the homeopathic repertorization symptoms observed in the 18 confirmed/suspected cases of COVID-19 in Hong Kong in early 2020 was reported. Methodology: A standard questionnaire on common homeopathic symptoms was filled in by all diagnosed/suspected COVID-19 patients, with or without the help of a consulting-room assistant, before the consultation. Repertorization symptoms from the case series were reported from 18 consecutive patients who used homeopathy as an adjunctive measure, in addition to the conventional or traditional chinese medicine, for symptomatic relief from COVID-19. Anonymized clinical information for research and academic purposes was used and approved by patients. The authors focused mainly on the homeopathic symptoms, i.e. the more individualised and characteristic symptoms which were available in the homeopathic repertories. In the presentation, the demographics, prevelance of homeopathic medicines, common repertorization symptoms in each of the top-ranked remedies, and differentiating symptoms for each top-ranked remedy were presented. Differentiating features were defined as homeopathic symptoms that were present in at least 50% of cases for the top-ranked remedy and in no more than 2 cases for other top-ranked remedies. The data collection project was further extended under the Clificol COVID-19 Support Project, a multinational, combined retrospective, and prospective longitudinal study. Results and discussion: Homeopathic symptoms of 18 cases were presented. All of the cases were categorized as mild. Eighteen common symptoms screened out of 79 selected repertorization symptoms constituted two sets of homeopathic symptom pictures: Bryonia alba (n = 4) and Gelsemium sempervirens (n = 12). Eight and seven differentiating features, respectively, were identified for Bryonia alba and Gelsemium sempervirens. Most updated data from the ongoing COVID-19 Support project was also presented. Conclusion: The common symptoms of 18 mild COVID-19 cases constituted two sets of homeopathic symptom pictures, indicating Bryonia alba or Gelsemium sempervirens; they were indicated in 4 and 12 cases, respectively, out of the 18 in total.</p> 2021-04-06T00:00:00+02:00 Copyright (c) 2021 Ka Lun Aaron To, Yuen Ying Yvonne Fok Homeopathy and the COVID-19 pandemic: quasi-experimental observational study 2021-03-14T16:06:59+01:00 Carla Holandino Adriana Passos Oliveira Edgard Costa Vilhena Twoany Rebecca Pedroza Sanches Fábio de Almeida Bolognani Eliane Turano Monteiro de Castro Torres Célia Maria Gouveia Vânia Emerich Bucco Campos Juliana Patrão Paiva Fortune Homsani Francisco José Freitas Leandro Machado Rocha <p><strong>Background: </strong>the number of cases of Covid-19 reached more than 11 million people in Brazil, but mostly in Caxias city (Rio de Janeiro) high death rates are very worrysome. In this scenario, homeopathy therapy, along with sanitary and therapeutic measures, should be recommended by health authorities. <strong>Aims: </strong>to evaluate the use of homeopathic complex (<em>Bryonia alba, China officinalis</em> and <em>Metallum album</em> 30cH), concerning the severity of the illness, during the coronavirus pandemic. <strong>Methodology: </strong>the complex was administrated at multiple families from Caxias, with (FW) and without (FWO) symptoms similar to COVID-19’s, therefore qualifying the project as a quasi-experimental longitudinal observational cohort study (applied in 51 families or 128 people). With this, the influence of homeopathic intervention in sick (FW) and health (FWO) groups was estimated. All volunteers used three drops of the medicine, once a day, per 60 days. The medicine was prepared accordingly to the Brazilian Homeopathic Pharmacopoeia<sup>1</sup>. The follow-up was carried out within seven days, which resulted in a total of 8 weeks, since the first interview. The data was organized and statistically analyzed with a 5% significance level, for categorical variables, by Fisher Exact test, in Excel sheet and SPSS 17.0 platform. The ethical committee approved this project under the code: CAAE 31601020.3.0000.5243. <strong>Results and Discussion: </strong>the preliminary results showed the absence of deaths in both groups (FW and FWO), without any statistically significant difference related to the severity of illness. Most of the families (98.03%) were thrilled to contribute in this particular homeopathic research and reported to have had general health symptoms’ improvements (84.31%). Despite the previous comorbidities presented in 52.9% of the families and considering that Covid-19 infected 0.020% of them, only 0.098% looked for medical assistance and none needed hospitalization. <strong>Conclusion: </strong>no differences between previous sick and health groups were detected after homeopathy intervention.</p> 2021-04-06T00:00:00+02:00 Copyright (c) 2021 Carla Holandino, Adriana Passos Oliveira, Edgard Costa Vilhena, Twoany Rebecca Pedroza Sanches Oliveira, Fábio de Almeida Bolognani, Eliane Turano Monteiro de Castro Torres, Célia Maria Gouveia, Vânia Emerich Bucco Campos, Juliana Patrão Paiva, Fortune Homsani, Francisco José Freitas, Leandro Machado Rocha Homeopathy and emotional disorders in children during covidian-19 pandemic 2021-03-14T16:26:11+01:00 Renata Rodrigues Garcia Lino Maria Solange Gosik Maria Filomena Xavier Mendes Isabella Sebusiani Duarte Takeuti Silvia Grosso Esher Danielle Barbas Giselle Iannarella Lacerda Cláudia Matera Turrini Izilda Aparecida Dechiare Davisson do Sacramento de Lucena Tavares Thais Perella Cunha Scigliano Rosemery Santos Silva Inês Dantas Ferraz Marçal <p>Background The period of social isolation, due to the Covid-19 Pandemic, impacted the children's social and family life in different ways. The whole family's feelings and emotions are intertwined, and everyone is involved in a broad awareness. Children, having a more developed intuitive awareness, receive all this in the form of subliminal inputs. At the moment, there is a concern regarding behavioral disorders in children and the risk of medicalization. The systemic view of Homeopathy can contribute to understanding this context. Aims: To contextualize the pediatric emotional disorders resulting from Pandemic in Carillo Júnior's view of Classic Systemic Homeopathy and list possible homeopathic medicines. Methodology: Bibliographic survey about emotional disorders in children during the Pandemic period. A theoretical review of the concept of disease in the view of classic systemic homeopathy and selection of drugs based on the method of repertorization of signs and symptoms. Results and discussion: The classification of diseases based on the Carillo Jr Complex Systems Model is based on the concept of prevalence between intrinsic and extrinsic factors. Through this model, we can understand what is being received by children as subliminal "inputs" since they do not assess the irrational conscience. Individual resilience and vulnerability will determine how they respond. Emotional and behavior disorders: distraction, irritability, fear, agitation, anxiety, poor sleep, nightmares. Main suggested drugs: Belladona, Chamomilla, Aconitum nappelus, Argentum nitricum, Gelsemium, Tarentula hispanica, Stramonium, Ignatia amara, Aurum metalicum, Cypripedium, Coffea cruda. Conclusion: The imposed social isolation leads to an excess of external inputs on the pediatric population, and the difficulty in processing them can lead to the emergence of emotional disorders. Therefore, as a cognitive therapy that acts on the self-regulation of the organism, homeopathy is an excellent, beneficial, and assertive tool.</p> 2021-04-06T00:00:00+02:00 Copyright (c) 2021 Renata Rodrigues Garcia Lino, Maria Solange Gosik, Maria Filomena Xavier Mendes, Isabella Sebusiani Duarte Takeuti, Silvia Grosso Esher, Danielle Barbas, Giselle Iannarella Lacerda, Cláudia Matera Turrini, Izilda Aparecida Dechiare, Davisson do Sacramento de Lucena Tavares, Thais Perella Cunha Scigliano, Rosemery Santos Silva, Inês Dantas Ferraz Marçal Clinical study of China officinalis in the view of classical systemic homeopathy during COVID-19 epidemic in São Paulo 2021-03-14T16:53:19+01:00 Maria Filomena Xavier Mendes Isabella Sebusiani Duarte Takeuti Luciana Valentini Melo Leticia Marilia de Almeida Werneck Santos Danielle da Silva Barbas Domingos José Vaz Cabo William Brunelli Hristos Strastis Renata Rodrigues Garcia Lino Leila Cristina dos Santos Mourão Adriana Passos Oliveira Maria Solange Gosik <p>Background: Brazilian Ministry of Health has reported 5.273.954 cases and 154.837 deaths from COVID-19 on October 20th, 2020. The first case of COVID-19 in Brazil occurred on February 26th, in São Paulo state. A total of 351.877 cases and 13.331 deaths were reported only in the city of São Paulo on October 20th. This scenario has severe health, economic, and social impact, as in other countries. Therefore, treatment strategies are urgently needed, such as Homeopathy that has shown excellent results in several epidemics. Aims: This study aims to describe the health signs and symptoms of some healthcare and essential professionals during the use of China officinalis. Methodology: Participants were professionals of the Server Public Municipal Hospital of São Paulo (HSPM), the Nossa Senhora Rainha da Paz Association (RP), and The Padre Bento Hospital (HPB). The homeopathic intervention was C. officinalis 6CH and a dosage of six drops per day. The study design was a time series with analysis by questionnaire before and after using homeopathic medicine. Statistical analyses were done by the McNemar test to compare qualitative data paired with a significance level of 5%. Ethical approval is CAAE 31802720.0.0000.5442. Results and discussion: Among the HSPM and RP participants, 83,1% did not develop symptoms while using C. officinalis and 16,9% developed symptoms while using C. officinalis. Among the HPB participants, 87,8 % did not develop symptoms while using C. officinalis and 12,2 % developed symptoms while using C. officinalis. . During the usage of C. officinalis, covid19-like symptoms were reduced with a significant difference (p&lt;0.05). Among the symptomatic, none of the participants needed intensive care hospitalization, supplemental oxygen, or intubation. Conclusion: C. officinalis was very acceptability by participants, and its use during the coronavirus pandemic contributed to health promotion.</p> 2021-04-06T00:00:00+02:00 Copyright (c) 2021 Maria Filomena Xavier Mendes, Isabella Sebusiani Duarte Takeuti, Luciana Valentini Melo, Leticia Marilia de Almeida Werneck Santos, Danielle da Silva Barbas, Domingos José Vaz Cabo, William Brunelli, Hristos Strastis, Renata Rodrigues Garcia Lino, Leila Cristina dos Santos Mourão, Adriana Passos Oliveira, Maria Solange Gosik Homeopathic medicine as health promotion during COVID-19 pandemic period in Niteroi city 2021-03-14T17:08:23+01:00 Adriana Passos Oliveira Maria da Conceição Farias Stern Cláudia Márcia Osório Xavier Almeida Fabio de Almeida Bolognani Carla Holandino Leandro Rocha <p>Background: According to the World Health Organization, the coronavirus disease 2019 (COVID-19) has 36.835.130 reported cases and 1.068.113 deaths worldwide on October 10, 2020. The city of Niterói has declared a public health emergency due to the COVID-19 pandemic with 13.906 reported cases, 3.03% of lethality, and 445 deaths. In this scenario, it is necessary to search for other forms of treatment such as Integrative Medicine, especially Homeopathy, which was used with excellent results in the great epidemics. Aims: Evaluate the use of the homeopathic medicine composed of Bryonia alba 30CH, China officinalis 30CH, and Metallum album 30CH in the health signs and symptoms of the health professionals of the Dr. Guilherme Taylor March Regional Polyclinic in Niterói. Ethical approval is CAAE 31601020.3.0000.5243. Methodology: The study design was a time series with analysis before and after using homeopathic medicine for eight weeks. Analysis of health signs and symptoms was carried out through a structured questionnaire. Statistical test was used to compare qualitative data paired with a significance level of 5%. Results and discussion: A total of 57 health professionals in face-to-face work used homeopathic medicine. No side effect was observed in all participants. The majority (84.2%) was without any flu-like symptoms before and after treatment. Nine participants (15.8%) had shown initial flu-like symptoms. After using homeopathic medicine, there was an improvement with a significant difference (p &lt;0.05). Among the symptomatic, six participants had a positive result in the covid test with significant improvement (p &lt;0.05) of the symptoms within seven days of using homeopathic medicine. Conclusion: The homeopathic intervention used during the coronavirus pandemic contributed as health promotion and adjunctive measure for symptomatic relief from COVID-19 and a treatment strategy that could be used as an adjunct to all sanitary and therapeutic measures recommended by health authorities.</p> 2021-04-06T00:00:00+02:00 Copyright (c) 2021 Adriana Passos Oliveira, Maria da Conceição Farias Stern, Cláudia Márcia Osório Xavier Almeida, Fabio de Almeida Bolognani, Carla Holandino, Leandro Rocha